Manifaxine
Manifaxine is a pharmaceutical drug that belongs to the class of antidepressants. It is primarily used in the treatment of major depressive disorder (MDD) and other related conditions. Manifaxine is known for its unique mechanism of action, which involves the modulation of various neurotransmitters in the brain.
Mechanism of Action
Manifaxine functions by inhibiting the reuptake of serotonin, norepinephrine, and dopamine, which are key neurotransmitters involved in mood regulation. By preventing the reabsorption of these neurotransmitters, Manifaxine increases their availability in the synaptic cleft, thereby enhancing neurotransmission and improving mood.
Indications
Manifaxine is indicated for the treatment of:
Dosage and Administration
Manifaxine is typically administered orally, with the dosage varying based on the severity of the condition and the patient's response to the treatment. It is important to follow the prescribed dosage and not to discontinue the medication abruptly to avoid withdrawal symptoms.
Side Effects
Common side effects of Manifaxine include:
Serious side effects may include:
Contraindications
Manifaxine is contraindicated in patients with:
- Known hypersensitivity to Manifaxine or any of its components
- Concurrent use of monoamine oxidase inhibitors (MAOIs)
- Severe liver impairment
Drug Interactions
Manifaxine may interact with other medications, including:
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Tricyclic antidepressants (TCAs)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
Pharmacokinetics
Manifaxine is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 2-4 hours after oral administration. It is metabolized primarily in the liver and excreted through the kidneys.
Research and Development
Ongoing research is being conducted to explore the potential of Manifaxine in treating other conditions such as bipolar disorder and post-traumatic stress disorder (PTSD).
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD